EMSP News MS Research

Innovative Drug Delivery Treatment for Multiple Sclerosis


The N2B-Patch is a project funded by the European Union, which brings together universities, research institutes, SMEs, industry and patients organisations to explore the possibility to have treatments (in MS) that bypass the Blood Brain Barrier (N2B-patch stands for Nose-to-Brain-patch).

Researchers aim to develop an innovative technology for multiple sclerosis (MS) treatment by developing a ‘nose to brain’ delivery system which will avoid the need for injections and oral medicine. The long-term objective is to improve treatment of MS patients.

The Nose to Brain Patch


Related Articles